Stock Report

Download full stock data and analysis for free Last Updated: 18-Oct-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Sheel Biotech Key Ratios

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: SHEEL

₹62.50

₹0.00 (0.00%)

As on 16-Oct-2026 09:48IST

Market cap

info icon

₹127 Cr

Revenue (TTM)

info icon

₹110 Cr

P/E Ratio

info icon

10.8

P/B Ratio

info icon

1

Div. Yield

info icon

0 %

Key Ratios and Highlights

Growth Score (%) Quarterly Annual (TTM)
Particulars QoQ YoY 1-Year 3-Years 5-Years
Revenue -- -- 8.13 11.15 11.79
EBIT -- -- 8.15 24.89 21.53
Net Profit -- -- 9.31 32.30 19.63
EPS -- -- -19.69 18.17 11.79
Book Value -- -- 11.24 12.51 9.80
Key Ratios (%) Average Annual (TTM)
Particulars3-Years5-YearsMar-26Mar-25Mar-24
EBIT-Margin info 14.0811.9413.8313.8314.59
Net Margin info 10.829.0310.6210.5211.32
Return on equity info 13.4211.2511.1513.7415.38
Return on Capital info 14.5212.0413.4314.7815.35
Return on Assets info 9.858.029.159.9110.49
Debt to Equity (x) info ----0.070.210.32

Profitability

View Detailed Peer Comparison

ROCE

13.43

No difference

Earning before interest and taxes / (Average net worth + Average total Debt) * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
13.43
14.78
15.35
9.50
7.16
Peer Median
13.43
21.79
0.14
--
--
ROE

11.15

No difference

Profit after tax / Average Net worth * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
11.15
13.74
15.38
8.24
7.75
Peer Median
11.15
16.17
0.10
--
--
ROA

9.15

No difference

Profit after tax / Average Total assets * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
9.15
9.91
10.49
5.43
5.14
Peer Median
9.15
12.16
0.09
--
--
EBIT Margin

13.83

--

Operating profit (EBIT) / Net Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
13.83
13.83
14.59
9.75
7.69
Peer Median
--
13.47
8.33
--
--
Net Margin

10.62

Lower than Peers by 1.57

Net profit / Total Income (Net sales plus other income) * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
10.62
10.52
11.32
6.33
6.35
Peer Median
12.19
11.21
9.71
--
--
Cash Profit Margin

11.65

--

(Net profit + Depreciation) / Gross Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
11.65
11.45
12.42
7.61
7.71
Peer Median
--
--
--
--
--

Growth

View Detailed Peer Comparison

Revenue Growth

8.13

--

Year on year growth in net sales

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
8.13
10.26
15.19
13.26
12.23
Peer Median
--
15.22
--
--
--
EBIT Growth

8.15

--

Year on year growth in operating profit (EBIT)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
8.15
4.49
72.39
43.57
-5.20
Peer Median
--
2,884.14
356.94
--
--
Net Profit Growth

9.31

--

Year on year growth in profit after tax

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
9.31
2.68
106.34
12.56
-5.99
Peer Median
--
-9.45
900.00
--
--
EPS Growth

-19.69

--

Year on year growth in earnings per share

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
-19.69
-0.41
106.34
12.56
-5.99
Peer Median
--
-28.73
--
--
--
Book Value Growth

51.41

--

Year on year growth in book value per share

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
51.41
15.38
14.40
6.35
5.35
Peer Median
--
--
--
--
--

Solvency

View Detailed Peer Comparison

Debt to Equity

0.07

No difference

Total debt / Net worth

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
0.07
0.21
0.32
0.30
0.39
Peer Median
0.07
0.04
0.03
--
--
Short term debt to equity ratio

0.06

--

(Short term borrowings / Net worth)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
0.06
0.15
0.18
0.12
0.15
Peer Median
--
--
--
--
--
Current Ratio

7.53

No difference

Current Assets / Current Liabilities and Provisions

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
7.53
4.49
4.22
4.04
4.25
Peer Median
7.53
3.93
6.31
--
--
Quick Ratio

5.79

--

(Current Assets - Inventory) / Current Liabilities and Provisions

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
5.79
2.71
2.77
3.10
3.65
Peer Median
--
3.81
3.62
--
--
Interest Coverage

8.32

Lower than Peers by 6.52

Earning before interest and taxes (EBIT) / Interest Expenses

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
8.32
8.26
9.28
5.19
4.90
Peer Median
14.85
25.59
51.60
--
--

Operating Efficiency

View Detailed Peer Comparison

Debtors to sales

56.17

--

Debtors outstanding / Net Sales * 100

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
56.17
54.13
62.53
69.96
91.48
Peer Median
--
24.55
23.00
--
--
Asset Turnover

0.86

--

Sales / Average Total Assets

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
0.86
0.94
0.92
0.86
0.81
Peer Median
--
3.19
3.90
--
--
Receivable days

193.88

--

Average Debtors / Sales * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
193.88
202.28
224.95
275.07
323.52
Peer Median
--
--
--
--
--
Inventory Days

114.37

--

Average Inventory / Sales * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
114.37
129.42
102.98
70.91
46.71
Peer Median
--
--
--
--
--
Payable days

25.83

--

Average Creditors / Cost of goods sold * 365

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
25.83
30.14
40.99
56.91
45.45
Peer Median
--
--
--
--
--
Cash Conversion Cycle

282.43

--

Receivable Days + Inventory Days - Payable Days

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
282.43
301.56
286.95
289.07
324.77
Peer Median
--
--
--
--
--

Valuation

View Detailed Peer Comparison

Price / Earnings

6.92

Lower than Peers by 7.96

Current share price divided by earning per share in the last twelve months

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
6.92
--
--
--
--
Peer Median
14.89
17.42
21.56
--
--
Price / Book Value

0.64

Lower than Peers by 0.37

Current share price divided by book value per share in the latest financial year

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
0.64
--
--
--
--
Peer Median
1.01
2.59
3.43
--
--
Dividend Yield

--

--

Dividend per share in the past twelve months divided by current share price

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
--
--
--
--
--
Peer Median
--
--
--
--
--
EV/EBITDA

5.19

Lower than Peers by 6.01

Enterprise Value (Current Market Capitalisation + Total Debt - Cash & Equivalents) / Earnings before interest, taxes, depreciation and taxes (EBITDA)

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
5.19
2.06
1.84
2.59
4.08
Peer Median
11.20
10.28
-11.31
--
--
Market Cap

81

Higher than Peers by 41

Current Share price multiplied by latest total number of shares outstanding

Company Name
Mar-26
Mar-25
Mar-24
Mar-23
Mar-22
Sheel Biotech
81
--
--
--
--
Peer Median
41
23
29
--
--
loading...
loading...
loading...